Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)
This grant opportunity aims to speed up the development of Digital Therapeutics (DTx) for treating Substance Use Disorders (SUDs). It focuses on creating safe and effective treatment platforms through mobile, web, or software-based technology. The goal is to achieve FDA authorization and make these treatments widely available. Applicants may work on developing or testing new or existing DTx.
The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of Digital Therapeutics (DTx) to treat Substance Use Disorders (SUDs). Advances in technology offer unprecedented opportunities to develop clinical-grade mobile, web, or other software-based platforms des…
Funding Source
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers